subject: CHEBI:4026

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities

tested_intervention: unsure


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:4027

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:4027

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:4027

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:4027

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UMLS:C5425888

subject_name: Inhaled iloprost

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C5425888

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C5425888

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:53394043


subject: PUBCHEM.COMPOUND:53394043


subject: PUBCHEM.COMPOUND:53394043


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

tested_intervention: yes


subject: PUBCHEM.COMPOUND:6435378


subject: PUBCHEM.COMPOUND:6435378


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: coronary artery disorder


subject: CHEBI:46195

object_name: coronary atherosclerosis


subject: MESH:C000621664

subject_name: Naltrexone-Bupropion combination

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C000621664

object_name: obesity


subject: MESH:C000621664

object_name: Obesity, CTCAE


subject: CHEBI:74926

subject_name: Patulin

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:74926

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:8774

subject_name: Ramipril

object_name: Rheumatic mitral stenosis


subject: CHEBI:8774

object_name: Mitral stenosis


subject: CHEBI:8774

object_name: rheumatic heart disease


subject: CHEBI:8774

object_name: Myocardial fibrosis


subject: UMLS:C5396052

subject_name: Inactivated whole Hepatitis A virus antigen only vaccine product

object_name: encephalitis


subject: CHEBI:64816

object_name: sarcomatoid renal cell carcinoma


subject: CHEBI:64816

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:64816

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Laceration


subject: CHEBI:4466

object_name: anxiety


subject: CHEBI:4466

object_name: anxiety disorder


subject: CHEBI:4466

object_name: Anxiety symptoms


subject: CHEBI:4466

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:4466

object_name: Anxiety, CTCAE 5.0


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:91825

subject_name: Dapt

object_name: stroke disorder


subject: CHEBI:91825

object_name: cerebrovascular disorder


subject: CHEBI:91825

object_name: Stroke (heart beat)


subject: CHEBI:91825

object_name: Stroke, CTCAE


subject: CHEBI:91825

object_name: Lacunar stroke


subject: UNII:949B9ZMO7M

subject_name: Diaminopropanol tetraacetic acid


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: thrombophilia due to thrombin defect


subject: CHEBI:31632

object_name: Venous thrombosis after immobility


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: type 1 diabetes mellitus 1


subject: CHEBI:17925

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17634


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEMBL.COMPOUND:CHEMBL4802175


subject: CHEMBL.COMPOUND:CHEMBL4802175


subject: UMLS:C4742625


subject: UMLS:C4742625


subject: UMLS:C3891716

subject_name: Compound Sodium Lactate Solution

object_name: Sepsis


subject: UMLS:C3891716

object_name: Sepsis, CTCAE


subject: UMLS:C3891716

object_name: coronary microvascular disorder


subject: UMLS:C3891716

object_name: Fluid Overload


subject: UMLS:C3891716

object_name: Hypervolemia


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:45783


subject: GTOPDB:1160

subject_name: hCG

object_name: Encounter due to In vitro fertilization


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa


subject: GTOPDB:4386

subject_name: FSH


subject: UMLS:C0016424

subject_name: Follicle stimulating hormone injectable


subject: CHEBI:81569

subject_name: Follitropin


subject: UMLS:C0016774

subject_name: Human Follicle-Stimulating Hormone


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:74705

subject_name: Met-Leu

object_name: dry eye syndrome


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C2608294

subject_name: Nasal Spray brand of phenylephrine


subject: CHEBI:64312

subject_name: Memantine

object_name: Compulsion


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: HIV infection


subject: CHEBI:84094

object_name: Cachexia


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:149504

object_name: cardiovascular disorder


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: hypertrophic cardiomyopathy


subject: CHEBI:32016

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:195544

subject_name: Aspartame

object_name: glucose intolerance


subject: CHEBI:195544

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:195544

object_name: hypoglycemia


subject: CHEBI:195544

object_name: hyperglycemia


subject: UMLS:C0003999

subject_name: aspartame


subject: UMLS:C0003999


subject: UMLS:C0003999


subject: UMLS:C0003999


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: CHEBI:17925


subject: CHEBI:17925


subject: CHEBI:17925


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:17234


subject: PUBCHEM.COMPOUND:21583979

subject_name: Saccharin sodium


subject: PUBCHEM.COMPOUND:21583979


subject: PUBCHEM.COMPOUND:21583979


subject: PUBCHEM.COMPOUND:21583979


subject: CHEBI:32111

subject_name: Saccharin


subject: CHEBI:32111


subject: CHEBI:32111


subject: CHEBI:32111


subject: UMLS:C2370269

subject_name: stevia extract


subject: UMLS:C2370269


subject: UMLS:C2370269


subject: UMLS:C2370269


subject: CHEBI:145012

subject_name: Rebaudioside A


subject: CHEBI:145012


subject: CHEBI:145012


subject: CHEBI:145012


subject: PUBCHEM.COMPOUND:5066234

subject_name: Sucralose


subject: PUBCHEM.COMPOUND:5066234


subject: PUBCHEM.COMPOUND:5066234


subject: PUBCHEM.COMPOUND:5066234


subject: CHEBI:499361

subject_name: Aprepitant

object_name: pancreatitis


subject: CHEBI:499361

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:499361

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:231614

subject_name: Nivolumab

object_name: mediastinal malignant lymphoma


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: atopic eczema


subject: UMLS:C3661059

object_name: Hypercholesterolemia


subject: UNII:5BSH2G9BH8

subject_name: Lucinactant


subject: UNII:5BSH2G9BH8

object_name: Acute lung injury/Acute respiratory distress syndrome (ARDS)


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Injury of digital nerve


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: MESH:D019444

subject_name: Vaccines, DNA

object_name: Oropharyngeal cancer recurrent


subject: MESH:D019444

object_name: Metastatic Oropharyngeal Carcinoma


subject: UMLS:C0390856

subject_name: human papillomavirus vaccine, TA


subject: UMLS:C0390856


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: cerebrovascular disorder


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: poorly differentiated thyroid gland carcinoma


subject: UNII:52CMI0WC3Y

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Thyroid Gland Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Unresectable Thyroid Gland Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEMBL.COMPOUND:CHEMBL2108210

subject_name: LAVENDER OIL

object_name: Nausea, CTCAE_5


subject: CHEMBL.COMPOUND:CHEMBL2108210

object_name: Nausea


subject: CHEMBL.COMPOUND:CHEMBL2108210

object_name: Nausea, CTCAE_3


subject: CHEMBL.COMPOUND:CHEMBL2108210

object_name: Suffering, Physical


subject: UMLS:C2365882

subject_name: mandarin oil


subject: UMLS:C2365882


subject: UMLS:C2365882


subject: UMLS:C2365882


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL


subject: CHEMBL.COMPOUND:CHEMBL2108758


subject: CHEMBL.COMPOUND:CHEMBL2108758


subject: CHEMBL.COMPOUND:CHEMBL2108758


subject: CHEBI:2549

subject_name: Albuterol

object_name: heart failure


subject: CHEBI:2549

object_name: congestive heart failure


subject: CHEBI:27300

object_name: Androgen excess


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: major injury


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C1134570

subject_name: Recombinant Fowlpox-TRICOM Vaccine

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C1134570

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C1134570

object_name: metastatic melanoma


subject: UMLS:C1134570

object_name: Melanoma recurrent


subject: DRUGBANK:DB16636

subject_name: Gastrodia elata whole

object_name: Masked Hypertension


subject: CHEBI:18258

subject_name: Liothyronine

object_name: outcomes general quality of life


subject: CHEBI:18258

object_name: Perceived quality of life


subject: CHEBI:18258

object_name: Good quality of life


subject: CHEBI:18258

object_name: Depressed mood


subject: CHEBI:18258

object_name: Cancer patients and suicide and depression


subject: CHEBI:18258

object_name: Depressed - symptom


subject: CHEBI:18258

object_name: Depression, CTCAE


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEBI:150712


subject: CHEBI:150712

object_name: Stiffness of knee, not elsewhere classified


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: left bundle branch hemiblock


subject: CHEBI:6888

object_name: Left bundle branch block


subject: CHEBI:6888

object_name: Left Bundle Branch Block Artifact


subject: CHEBI:6888

object_name: Left Bundle Branch Block by ECG Finding


subject: CHEBI:50858

subject_name: corticosteroid


subject: CHEBI:50858


subject: CHEBI:50858


subject: CHEBI:50858


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C2987384

subject_name: BMN 673

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987384

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C2987384

object_name: Ovarian mass


subject: UMLS:C2987384

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2987384

object_name: primary peritoneal serous adenocarcinoma


subject: UMLS:C2987384

object_name: peritoneal serous adenocarcinoma


subject: UMLS:C2987384

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2987384

object_name: Ovarian cancer stage III


subject: UMLS:C2987384

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2987384

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2987384

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2987384

object_name: fallopian tube serous adenocarcinoma


subject: UMLS:C2987384

object_name: high grade ovarian serous adenocarcinoma


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8313

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8313

object_name: Ovarian mass


subject: GTOPDB:8313

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: GTOPDB:8313

object_name: primary peritoneal serous adenocarcinoma


subject: GTOPDB:8313

object_name: peritoneal serous adenocarcinoma


subject: GTOPDB:8313

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: GTOPDB:8313

object_name: Ovarian cancer stage III


subject: GTOPDB:8313

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: GTOPDB:8313

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: GTOPDB:8313

object_name: Stage IIIC Ovarian Cancer


subject: GTOPDB:8313

object_name: fallopian tube serous adenocarcinoma


subject: GTOPDB:8313

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:93847

subject_name: Aceclidine

object_name: Ametropia


subject: CHEBI:93847

object_name: eye disorder


subject: CHEBI:36080

subject_name: protein

object_name: Ketosis


subject: CHEBI:36080

object_name: Ketoacidosis


subject: UMLS:C0033684

subject_name: Proteins


subject: UMLS:C0033684


subject: PR:000000001


subject: PR:000000001


subject: CHEBI:70839

subject_name: Dasatinib

object_name: peritoneum cancer


subject: CHEBI:70839

object_name: ovarian cancer


subject: CHEBI:70839

object_name: ovarian neoplasm


subject: CHEBI:70839

object_name: ovarian carcinoma


subject: CHEBI:70839

object_name: fallopian tube carcinoma


subject: CHEBI:70839

object_name: fallopian tube cancer


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Disorder of androgen receptor


subject: CHEBI:132922

object_name: Premature birth


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: PR:000004614

subject_name: bile acid-CoA:amino acid N-acyltransferase

object_name: COPD, severe early onset


subject: PR:000004614

object_name: chronic obstructive pulmonary disease


subject: PR:000010390

subject_name: microsomal glutathione S-transferase 1


subject: PR:000010390


subject: CHEBI:16302

object_name: malaria


subject: CHEBI:16302

object_name: malnutrition


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: GTOPDB:13870

object_name: Overweight and obesity


subject: UMLS:C5690553


subject: CHEBI:42567

subject_name: Fisetin

object_name: Frail elderly syndrome


subject: MESH:D002214

subject_name: Capsules

object_name: liver cancer


subject: UMLS:C5139949

object_name: atopic eczema


subject: CHEBI:3766

subject_name: Clozapine

object_name: bipolar disorder


subject: CHEBI:231614

subject_name: Nivolumab

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C2346820


subject: CHEBI:94531

subject_name: belinostat

object_name: brain glioblastoma


subject: RXCUI:2665904

subject_name: albuterol / budesonide Inhalant Product

object_name: asthma


subject: RXCUI:2665904

object_name: Acute asthma


subject: CHEBI:49086

object_name: perinatal asphyxia


subject: CHEBI:49086

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:49086

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:49086

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:16436


subject: CHEBI:16436


subject: CHEBI:16436


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:4934

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:4934

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Myelodysplasia


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C4329337

subject_name: TAB 001

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:41423

subject_name: Celecoxib

object_name: osteoarthritis, knee


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:64030

subject_name: tetrabenazine

object_name: schizophrenia


subject: CHEBI:64030

object_name: schizoaffective disorder


subject: CHEBI:64030

object_name: schizophrenia 18


subject: UMLS:C0064332

subject_name: keyhole-limpet hemocyanin

object_name: Childhood Neuroblastoma


subject: UMLS:C0064332

object_name: neuroblastoma


subject: UMLS:C0064332

object_name: nervous system cancer


subject: CHEBI:6441

subject_name: Levacetylmethadol

object_name: substance-related disorder


subject: CHEBI:135491

subject_name: acetylmethadol


subject: CHEBI:135332

subject_name: Dimepheptanol


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: fibromyalgia


subject: CHEBI:35812

subject_name: Oxfendazole

object_name: Tenia solium infection


subject: CHEBI:32181

subject_name: Tamibarotene

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:32181

object_name: acute myeloid leukemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Carcinoma breast stage IV


subject: UMLS:C2346820


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: abortion in first trimester


subject: CHEBI:15647

subject_name: Leukotriene B4

object_name: dermatitis


subject: CHEBI:15647

object_name: Dermatitis


subject: CHEBI:63981

subject_name: 6-trans-leukotriene B4


subject: CHEBI:63981


subject: CHEBI:57461

subject_name: leukotriene B4(1-)


subject: CHEBI:57461


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: dry eye syndrome


subject: UNII:105J35OE21

subject_name: Aducanumab

object_name: Alzheimer disease


subject: UMLS:C4519523


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Critical Illness


subject: CHEBI:85078

object_name: Sepsis


subject: CHEBI:85078

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:123812

subject_name: heliox

object_name: obstructive sleep apnea syndrome


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: liver cirrhosis


subject: CHEBI:31300

object_name: Hermansky-Pudlak syndrome


subject: CHEBI:31300

object_name: hepatopulmonary syndrome


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101

object_name: liver carcinoma


subject: UMLS:C2348637


subject: CHEBI:231614

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage I Renal Cell Carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:4470

subject_name: Dextromethorphan

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:4470

object_name: amyotrophic lateral sclerosis


subject: UNII:J13S2394HE

subject_name: QUINIDINE SULFATE


subject: UNII:J13S2394HE


subject: CHEBI:94416


subject: CHEBI:94416


subject: CHEBI:28482

subject_name: quinidine sulfate


subject: CHEBI:28482


subject: CHEBI:28593

subject_name: Quinidine


subject: CHEBI:28593


subject: CHEBI:6822

subject_name: Methazolamide

object_name: open-angle glaucoma


subject: DRUGBANK:DB17831

subject_name: Beremagene geperpavec

object_name: epidermolysis bullosa dystrophica


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: pain agnosia


subject: CHEBI:5779

object_name: Pain insensitivity


subject: CHEBI:5779

object_name: Post-Operative Pain


subject: CHEBI:3219

subject_name: Bupropion

object_name: HIV infection


subject: CHEBI:4445

subject_name: Desflurane

object_name: clonic hemifacial spasm


subject: CHEBI:4445

object_name: Hemifacial spasm


subject: UMLS:C4759868

subject_name: NY-ESO-1 plasmid DNA cancer vaccine

object_name: prostate carcinoma


subject: UMLS:C4759868

object_name: prostate cancer


subject: UMLS:C4759868

object_name: bladder tumor


subject: UMLS:C4759868

object_name: urinary bladder carcinoma


subject: UMLS:C4759868

object_name: urinary bladder cancer


subject: UMLS:C4759868

object_name: childhood bladder carcinoma


subject: UMLS:C4759868

object_name: carcinoma of esophagus


subject: UMLS:C4759868

object_name: esophageal cancer


subject: UMLS:C4759868

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4759868

object_name: neoplasm of esophagus


subject: UMLS:C4759868

object_name: non-small cell lung carcinoma


subject: UMLS:C4759868

object_name: malignant soft tissue neoplasm


subject: UMLS:C4759868

object_name: sarcoma


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Fetal alcohol exposure


subject: CHEBI:16822

object_name: fetal alcohol spectrum disorder


subject: CHEBI:16822

object_name: fetal alcohol syndrome


subject: CHEBI:16822

object_name: Fetus or newborn affected by alcohol transmitted via placenta or breast milk


subject: CHEBI:16822

object_name: partial fetal alcohol syndrome


subject: CHEBI:16822

object_name: Alcohol Related Neurodevelopmental Disorder


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:15354


subject: CHEBI:15354


subject: CHEBI:15354


subject: CHEBI:15354


subject: CHEBI:15354


subject: CHEBI:52717

subject_name: Bortezomib

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:95341

subject_name: Baricitinib

object_name: temporal arteritis


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Crushing injury


subject: CHEBI:34385

object_name: reported crush injury of tissue (history)


subject: CHEBI:34385

object_name: peripheral nerve injury


subject: UMLS:C0935889

subject_name: GASTRIMMUNE

object_name: colorectal cancer


subject: UMLS:C0935889

object_name: colorectal carcinoma


subject: UMLS:C0935889

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C3658787


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Fatigue, CTCAE 5.0


subject: PUBCHEM.COMPOUND:2767

object_name: Fatigue


subject: PUBCHEM.COMPOUND:2767

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:2767

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:2767

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:2767

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:2767

object_name: anxiety disorder


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118

object_name: lung cancer


subject: CHEBI:5118

object_name: lung neoplasm


subject: CHEBI:5118

object_name: lung carcinoma


subject: CHEBI:5118


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: UMLS:C3641122


subject: CHEBI:3139

subject_name: bleomycin

object_name: diffuse large B-cell lymphoma


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Myelofibrosis due to another disorder


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: myeloproliferative neoplasm


subject: UNII:19J3781LPM

object_name: Malignant myeloproliferative neoplasm


subject: UNII:19J3781LPM

object_name: Myelodysplasia


subject: UNII:19J3781LPM

object_name: Adult Myelodysplastic Syndrome


subject: UNII:19J3781LPM

object_name: childhood myelodysplastic syndrome


subject: UNII:19J3781LPM

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:19J3781LPM

object_name: juvenile myelomonocytic leukemia


subject: UNII:19J3781LPM

object_name: chronic myelomonocytic leukemia


subject: UNII:19J3781LPM

object_name: acute lymphoblastic leukemia


subject: UNII:19J3781LPM


subject: UNII:19J3781LPM

object_name: acute myeloid leukemia by FAB classification


subject: UNII:19J3781LPM

object_name: acute myeloid leukemia


subject: UNII:19J3781LPM

object_name: myelofibrosis


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:63925

subject_name: PhXa 85

object_name: alopecia areata


subject: CHEBI:63925

object_name: alopecia


subject: CHEBI:60799

subject_name: Esketamine

object_name: bipolar depression


subject: MESH:C000619755

object_name: Childhood Solid Neoplasm


subject: MESH:C000619755

object_name: Adult Solid Neoplasm


subject: MESH:C000619755

object_name: Solid Neoplasm


subject: MESH:C000619755

object_name: colorectal cancer


subject: MESH:C000619755

object_name: colorectal carcinoma


subject: CHEBI:63724

object_name: malignant soft tissue neoplasm


subject: CHEBI:63724

object_name: sarcoma


subject: UMLS:C5782788

subject_name: ROPivacaine 0.1% injectable solution

object_name: respiratory paralysis


subject: UMLS:C5782788

object_name: Diaphragmatic paralysis


subject: UMLS:C5959692

subject_name: CSF-1R/DDR1/VEGFR2 Inhibitor C019199


subject: UMLS:C5959692


subject: UMLS:C5959692


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: Prognathism


subject: UNII:3M6325NY1R

object_name: autosomal dominant prognathism


subject: UNII:3M6325NY1R

object_name: Retrognathia


subject: UNII:3M6325NY1R

object_name: Congenital facial asymmetry


subject: UNII:3M6325NY1R

object_name: hemifacial hypertrophy


subject: UNII:3M6325NY1R

object_name: Facial asymmetry


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:082285VIDF

object_name: Adult Soft Tissue Sarcoma


subject: UNII:082285VIDF


subject: UNII:082285VIDF

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:082285VIDF

object_name: soft tissue sarcoma


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18


subject: UNII:8MSY49469G


subject: UNII:8MSY49469G


subject: UNII:8MSY49469G


subject: UNII:8MSY49469G


subject: CHEBI:7936

subject_name: Paroxetine

object_name: anxiety disorder


subject: UMLS:C2348194

object_name: Solid Neoplasm


subject: UMLS:C2348194

object_name: cancer


subject: UMLS:C2348194

object_name: neoplasm


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: nicotine dependence


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: anemia


subject: UMLS:C2984024

object_name: Iron deficiency


subject: UMLS:C5203385

subject_name: Ferric Carboxymaltose Liquid Injection


subject: UMLS:C5203385


subject: UMLS:C5203385

object_name: iron deficiency anemia


subject: UNII:B5TAN0L720

subject_name: Picoplatin

object_name: lung cancer


subject: UNII:B5TAN0L720

object_name: lung neoplasm


subject: UNII:B5TAN0L720

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3544907

subject_name: PICOPLATIN


subject: CHEMBL.COMPOUND:CHEMBL3544907


subject: CHEMBL.COMPOUND:CHEMBL3544907


subject: MESH:C000722716

subject_name: SYS6006 COVID-19 vaccine


subject: MESH:C000722716

object_name: Immunotoxicity


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Hodgkin Disease


subject: UNII:6QVL057INT

object_name: Adult Hodgkin Lymphoma


subject: UNII:6QVL057INT

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: HMDB:HMDB0014612

subject_name: Tenoxicam

object_name: osteoarthritis, knee


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: phenylketonuria


subject: CHEBI:73604

object_name: classic phenylketonuria


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: squamous cell lung carcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:5441

subject_name: Glyburide

object_name: acute spinal cord injury


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Carcinoma breast stage IV


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:66919


subject: UNII:YET2XNU791

object_name: leukemia


subject: UNII:YET2XNU791

object_name: childhood leukemia


subject: UMLS:C5418168

subject_name: Fadraciclib


subject: UMLS:C5418168


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB

object_name: transitional cell carcinoma


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: Surgical Wound Infection


subject: UMLS:C5555004

subject_name: Izalontamab

object_name: colorectal cancer


subject: UMLS:C5555004

object_name: colorectal carcinoma


subject: UMLS:C5555004

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Neuralgia, CTCAE


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:44185

subject_name: Methotrexate

object_name: acute graft versus host disease


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: brain injury


subject: PUBCHEM.COMPOUND:78097275

subject_name: Vaniprevir

object_name: chronic hepatitis C virus infection


subject: CHEBI:188804

subject_name: Telapristone acetate

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: breast carcinoma in situ


subject: CHEBI:188804

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:188804

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:188804

object_name: stage IA breast cancer


subject: CHEBI:188804

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:188804

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:188804

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:188804

object_name: ductal breast carcinoma in situ


subject: CHEBI:188804

object_name: lobular breast carcinoma in situ


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Mantle cell lymphoma refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: Mantle cell lymphoma recurrent


subject: PR:000002107

subject_name: tumor necrosis factor ligand superfamily member 11

object_name: osteoporosis


subject: PR:000002107

object_name: Encounter due to family history of osteoporosis


subject: PR:000002107

object_name: Osteoporosis, CTCAE 5.0


subject: PR:000002107

object_name: Osteoporosis, CTCAE 3.0


subject: PR:000002107

object_name: EXCESS LMW-DNA


subject: CHEBI:8378

subject_name: Prednisolone

object_name: prostate carcinoma


subject: CHEBI:8378

object_name: prostate cancer


subject: DRUGBANK:DB18260

object_name: cystic fibrosis


subject: UNII:349552KRHK

subject_name: Simendan

object_name: heart failure


subject: UNII:349552KRHK

object_name: Heart Failure, CTCAE


subject: UNII:349552KRHK

object_name: ST-elevation myocardial infarction


subject: UNII:349552KRHK

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: Graft Rejection


subject: UNII:CHL9B67L95

subject_name: Olmutinib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135415564

subject_name: Rifabutin

object_name: tuberculosis


subject: CHEBI:45367


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: esophageal squamous cell carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: CHEBI:68554

subject_name: Deferiprone

object_name: myelodysplastic syndrome with low-grade lesions


subject: CHEBI:68554

object_name: Iron overload due to repeated red blood cell transfusions


subject: UMLS:C5854437

subject_name: XBH 25

object_name: Adult Solid Neoplasm


subject: UMLS:C5854437

object_name: refractory malignant neoplasm


subject: UMLS:C5854437

object_name: skin melanoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Colorectal cancer recurrent


subject: CHEBI:91400

subject_name: Afatinib

object_name: chordoma


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: Nasal congestion


subject: CHEBI:6704

subject_name: Mebendazole

object_name: parasitic infectious disease


subject: CHEBI:45267

subject_name: praziquantel


subject: CHEBI:91583

subject_name: Praziquantel


subject: UMLS:C2700362

subject_name: Lymphoseek

object_name: colon carcinoma


subject: UMLS:C2700362

object_name: colorectal cancer


subject: UMLS:C2700362

object_name: colon cancer


subject: UMLS:C2700362

object_name: rectal carcinoma


subject: UMLS:C2700362

object_name: rectal cancer


subject: UMLS:C2700362

object_name: Childhood Rectal Carcinoma


subject: UMLS:C3493806

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3493806


subject: DRUGBANK:DB05559

subject_name: NF-kappaB Decoy

object_name: atopic eczema


subject: GTOPDB:12962

subject_name: sotatercept

object_name: Myelodysplasia


subject: GTOPDB:12962

object_name: chronic myelomonocytic leukemia


subject: GTOPDB:12962

object_name: juvenile myelomonocytic leukemia


subject: GTOPDB:12962

object_name: anemia


subject: GTOPDB:12962

object_name: Anemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pediatric angiosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: angiosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Angiosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: leiomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Leiomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Leiomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: histiocytoma


subject: UNII:2S9ZZM9Q9V

object_name: cutaneous fibrous histiocytoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: malignant soft tissue neoplasm


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:41423

subject_name: Celecoxib

object_name: cancer


subject: CHEBI:41423

object_name: neoplasm


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:78420

subject_name: Icariin

object_name: acne


subject: CHEBI:78420

object_name: Acne scar


subject: PUBCHEM.COMPOUND:70675843

subject_name: Levophencynonate hydrochloride

object_name: motion sickness


subject: UNII:MOI46704GT

subject_name: LEVOPHENCYNONATE HYDROCHLORIDE


subject: UMLS:C1328728

object_name: peritoneum cancer


subject: UMLS:C1328728

object_name: Recurrent ovarian cancer


subject: CHEBI:52717

subject_name: Bortezomib

object_name: amyloidosis


subject: PUBCHEM.COMPOUND:60918

subject_name: tegaserod

object_name: opioid-induced constipation


subject: CHEBI:184662

object_name: AIDS


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: UMLS:C3661192

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:45380979

subject_name: RONICICLIB


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: endometriosis


subject: UMLS:C0962483

object_name: focal epilepsy


subject: UMLS:C2347903

subject_name: Recombinant Adenovirus-Interferon SCH 721015

object_name: bladder tumor


subject: UMLS:C2347903

object_name: urinary bladder carcinoma


subject: UMLS:C2347903

object_name: urinary bladder cancer


subject: UMLS:C2347903

object_name: childhood bladder carcinoma


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Failure to thrive in infant


subject: CHEBI:36005

object_name: Undergrowth


subject: CHEBI:36005

object_name: Failure to Thrive


subject: CHEBI:36005

object_name: cystic fibrosis


subject: CHEBI:36005

object_name: malnutrition


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:22586

subject_name: antioxidant


subject: CHEBI:22586


subject: CHEBI:22586


subject: CHEBI:22586


subject: CHEBI:22586


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: autoimmune thrombocytopenia


subject: CHEBI:41879

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:41879

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0282042

object_name: ependymoblastoma


subject: UMLS:C0282042

object_name: Typical Teratoid Rhabdoid Tumor


subject: UMLS:C0282042

object_name: medulloepithelioma


subject: UMLS:C0282042

object_name: medulloblastoma


subject: UMLS:C0282042

object_name: childhood medulloblastoma


subject: UMLS:C0282042

object_name: adult medulloblastoma


subject: UMLS:C0282042

object_name: Childhood Neuroblastoma


subject: UMLS:C0282042

object_name: neuroblastoma


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Carcinoma breast stage IV


subject: CHEBI:229213

object_name: hormone receptor-positive breast cancer


subject: CHEBI:229213

object_name: Hormone receptor negative HER2 positive breast cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UNII:4O87Q44KNC


subject: UNII:4O87Q44KNC


subject: UNII:4O87Q44KNC


subject: UMLS:C5418191

subject_name: Vosilasarm


subject: UMLS:C5418191


subject: UMLS:C5418191


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Osteosarcoma recurrent


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Onset of labor induced (finding)


subject: UMLS:C3813211

subject_name: Prostaglandin E2


subject: MESH:D013607

subject_name: Tablets


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Rotator cuff tear


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: allergic asthma


subject: PUBCHEM.COMPOUND:5281767

object_name: IgE-mediated allergic asthma


subject: PUBCHEM.COMPOUND:5281767

object_name: extrinsic asthma


subject: CHEBI:231324

subject_name: alpelisib

object_name: breast neoplasm


subject: CHEBI:231324

object_name: kidney neoplasm


subject: CHEBI:231324

object_name: kidney cancer


subject: CHEBI:231324

object_name: neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: High grade glioma


subject: CHEBI:63791

object_name: malignant glioma


subject: CHEBI:63791

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:63791

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:63791

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:63791

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:63791

object_name: anaplastic astrocytoma


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: dysfunction; endocrine


subject: CHEBI:84094

object_name: Physical trauma


subject: CHEBI:84094

object_name: Injury


subject: CHEBI:84094

object_name: Trauma


subject: CHEBI:84094

object_name: brain injury


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: PUBCHEM.COMPOUND:5281767

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:5281767

object_name: amyotrophic lateral sclerosis


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UMLS:C5690426


subject: CHEBI:135005

subject_name: Milnacipran

object_name: fibromyalgia


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: bacterial pneumonia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:172866837

subject_name: Enlicitide Decanoate

object_name: Hypercholesterolemia


subject: UNII:PSR59MCX5M

subject_name: ENLICITIDE DECANOATE


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: stage IIIC melanoma


subject: UNII:M89N0Q7EQR

object_name: stage IIIA melanoma


subject: UNII:M89N0Q7EQR

object_name: stage IIIB melanoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: Melanoma recurrent


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C0281722

subject_name: gp100 Antigen


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C4329337

subject_name: TAB 001

object_name: melanoma


subject: UMLS:C4329337

object_name: malignant urinary system neoplasm


subject: CHEBI:133021

subject_name: Venetoclax

object_name: marginal zone lymphoma


subject: CHEBI:133021

object_name: MALT lymphoma


subject: CHEBI:28830

subject_name: Chlorambucil

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Thrombotic Disorder


subject: CHEBI:28939

object_name: thrombosis


subject: PUBCHEM.COMPOUND:122316


subject: PUBCHEM.COMPOUND:122316


subject: CHEBI:63620

subject_name: Rasagiline


subject: CHEBI:63620


subject: CHEBI:174615

object_name: Rare genetic disease


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:91872

object_name: Kaposi Sarcoma


subject: CHEBI:91872

object_name: HIV infection


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:63631

subject_name: Topiramate

object_name: Headache


subject: CHEBI:63631

object_name: Headache, CTCAE


subject: CHEBI:63631

object_name: dizziness


subject: CHEBI:63631

object_name: Dizziness, CTCAE 5.0


subject: CHEBI:63631

object_name: Dizziness, CTCAE 3.0


subject: UMLS:C5787279

subject_name: MEK Inhibitor PF-07799544


subject: UMLS:C5787279

object_name: thyroid tumor


subject: UMLS:C5787279

object_name: thyroid gland carcinoma


subject: UMLS:C5787279

object_name: thyroid cancer


subject: UMLS:C5787279

object_name: colorectal cancer


subject: UMLS:C5787279

object_name: colorectal carcinoma


subject: UMLS:C5787279

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5787279

object_name: non-small cell lung carcinoma


subject: UMLS:C5787279

object_name: cancer


subject: UMLS:C5787279

object_name: nervous system cancer


subject: UMLS:C5787279

object_name: brain cancer


subject: UMLS:C5787279

object_name: brain neoplasm


subject: UMLS:C5787279

object_name: glioma


subject: UMLS:C5787279

object_name: malignant glioma


subject: DRUGBANK:DB17489

object_name: melanoma


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: DRUGBANK:DB17489


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Childhood Breast Carcinoma


subject: CHEBI:194186

object_name: breast carcinoma


subject: CHEBI:194186

object_name: breast cancer


subject: CHEBI:194186

object_name: breast neoplasm


subject: CHEBI:167655

object_name: unspecified adult solid tumor, protocol specific


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: Post-Operative Pain


subject: CHEBI:135720

subject_name: Deflazacort

object_name: Duchenne muscular dystrophy


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579

object_name: neoplasm


subject: CHEBI:7772

subject_name: omeprazole

object_name: Fatty Liver


subject: CHEBI:7772

object_name: Decreased liver function


subject: CHEBI:7772

object_name: type 2 diabetes mellitus


subject: CHEBI:7772

object_name: Insulin resistance


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: CHEBI:51254


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: UNII:HS813P8QPX

subject_name: bismuth subcitrate


subject: UNII:HS813P8QPX


subject: UNII:HS813P8QPX


subject: UNII:HS813P8QPX


subject: PUBCHEM.COMPOUND:2269


subject: PUBCHEM.COMPOUND:2269


subject: PUBCHEM.COMPOUND:2269


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: systemic inflammatory response syndrome


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: tinea unguium


subject: CHEBI:66889

subject_name: Peginesatide

object_name: cancer


subject: CHEBI:66889


subject: UMLS:C1710272

subject_name: hematide


subject: UMLS:C1710272


subject: CHEBI:32599

object_name: Hypotonia


subject: UNII:2372V1TKXK

subject_name: Lanadelumab

object_name: hereditary angioedema


subject: UMLS:C4044724


subject: CHEBI:31355

subject_name: Carboplatin

object_name: seminoma


subject: CHEBI:31355

object_name: testicular germ cell tumor


subject: CHEBI:31355

object_name: testis seminoma


subject: CHEBI:31355

object_name: malignant testicular germ cell tumor


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: neoplasm of testis


subject: PUBCHEM.COMPOUND:2767

object_name: testicular cancer


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UMLS:C2348466


subject: UMLS:C2348466


subject: CHEBI:232799

subject_name: insulin lispro

object_name: type 1 diabetes mellitus


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: lung cancer


subject: UNII:0JSR7Z0NB6

object_name: lung neoplasm


subject: UNII:0JSR7Z0NB6

object_name: lung carcinoma


subject: UMLS:C4085970


subject: UMLS:C4085970


subject: UMLS:C4085970


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Non-small cell carcinoma


subject: UMLS:C3827082


subject: UMLS:C3658787

object_name: non-small cell lung carcinoma


subject: UMLS:C3658787


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:91899

object_name: chronic rhinosinusitis


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Chronic Post-Traumatic Stress Disorder


subject: CHEBI:43830

subject_name: Methylthioninium


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: traumatic encephalopathy


subject: UNII:37KZM6S21G

object_name: traumatic brain injury


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: CHEBI:78351

subject_name: amantadine sulfate


subject: CHEBI:78351


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Alzheimer disease


subject: CHEBI:174428

object_name: primary biliary cholangitis


subject: MESH:D002214

subject_name: Capsules


subject: UMLS:C0525959

object_name: Childhood Breast Carcinoma


subject: UMLS:C0525959

object_name: breast carcinoma


subject: UMLS:C0525959

object_name: breast cancer


subject: MESH:C407042

subject_name: plant stanol ester

object_name: Hypercholesterolemia


subject: MESH:C407042

object_name: hyperlipidemia


subject: MESH:C407042

object_name: Dyslipidemia


subject: UNII:0T4IMT8S5Z

subject_name: Olutasidenib

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:0T4IMT8S5Z

object_name: diffuse intrinsic pontine glioma


subject: UNII:0T4IMT8S5Z

object_name: High grade glioma


subject: UNII:0T4IMT8S5Z

object_name: malignant glioma


subject: UNII:0T4IMT8S5Z

object_name: glioblastoma


subject: UNII:0T4IMT8S5Z

object_name: grade III glioma


subject: UNII:0T4IMT8S5Z

object_name: anaplastic astrocytoma


subject: UNII:0T4IMT8S5Z

object_name: glioma susceptibility 1


subject: UNII:0T4IMT8S5Z

object_name: adult oligodendroglioma


subject: UNII:0T4IMT8S5Z

object_name: oligodendroglioma


subject: UNII:0T4IMT8S5Z

object_name: childhood oligodendroglioma


subject: UNII:0T4IMT8S5Z

object_name: metastatic malignant neoplasm in the brain


subject: UNII:0T4IMT8S5Z


subject: UNII:0T4IMT8S5Z

object_name: thalamic cancer


subject: UNII:0T4IMT8S5Z

object_name: Spinal Neoplasm


subject: UNII:0T4IMT8S5Z

object_name: Childhood Astrocytoma


subject: UNII:0T4IMT8S5Z

object_name: astrocytic tumor


subject: UNII:0T4IMT8S5Z

object_name: astrocytoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C4687482

subject_name: BRD4 Inhibitor PLX2853

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4687482

object_name: Ovarian clear cell carcinoma


subject: UMLS:C4687482

object_name: ovarian clear cell cancer


subject: UMLS:C4687482

object_name: small cell lung carcinoma


subject: UMLS:C4687482

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4687482

object_name: non-Hodgkin lymphoma


subject: UMLS:C4687482

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4687482

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4687482

object_name: follicular lymphoma


subject: UMLS:C4687482

object_name: uveal melanoma


subject: UMLS:C4687482

object_name: Childhood Solid Neoplasm


subject: UMLS:C4687482

object_name: Adult Solid Neoplasm


subject: UMLS:C4687482

object_name: Solid Neoplasm


subject: UNII:Z633861EIM

subject_name: Asfotase alfa

object_name: pyropoikilocytosis, hereditary


subject: UNII:Z633861EIM

object_name: hypophosphatasia


subject: UMLS:C2981232

subject_name: EP-100 membrane-disrupting peptide


subject: CHEBI:32184

subject_name: Tazarotene


subject: CHEBI:32184


subject: CHEBI:32184


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cystic fibrosis


subject: CHEBI:7421

subject_name: NAC


subject: PUBCHEM.COMPOUND:378119

subject_name: Panzem NCD

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:378119

object_name: prostate cancer


subject: UMLS:C1831866


subject: UMLS:C1831866


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: endophthalmitis


subject: CHEBI:63611

object_name: Endophthalmitis, CTCAE


subject: CHEBI:63611

object_name: cataract


subject: CHEBI:63611

object_name: Cataract, CTCAE 3.0


subject: CHEBI:63611

object_name: Cataract, CTCAE 5.0


subject: CHEBI:63611

object_name: cataract on exam (physical finding)


subject: CHEBI:63611

object_name: edema; macula


subject: PR:000002089

subject_name: signal transducer and activator of transcription 3

object_name: Surgical wound, healed


subject: PR:000002089

object_name: Post-Operative Pain


subject: CHEBI:2955

subject_name: Azithromycin

object_name: recurrent pneumonia


subject: CHEBI:2955

object_name: Lung Infection, CTCAE


subject: MESH:C549285

subject_name: Custodiol-N solution

object_name: kidney failure


subject: MESH:C549285

object_name: chronic liver failure


subject: UMLS:C4051515

subject_name: PCSK9 Inhibitor [EPC]

object_name: acute myocardial infarction


subject: UMLS:C4051515

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C4521460

subject_name: Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action


subject: UMLS:C4521460


subject: UMLS:C3713905

object_name: chronic obstructive pulmonary disease


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C3896868

subject_name: TLR9 Agonist DUK-CPG-001

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3896868

object_name: non-Hodgkin lymphoma


subject: UMLS:C3896868

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3896868

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3896868

object_name: Hodgkin Disease


subject: UMLS:C3896868

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C3896868

object_name: Childhood Hodgkin Lymphoma


subject: UNII:B669M62ELP

subject_name: MRX-I

object_name: Joint problem


subject: UNII:B669M62ELP

object_name: tuberculosis


subject: UNII:V4E0A9M44Q

subject_name: Etavopivat

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Alzheimer disease


subject: MESH:D000096983

subject_name: Ginkgo Extract


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba


subject: CHEBI:94463

object_name: mantle cell lymphoma


subject: CHEBI:94463

object_name: follicular lymphoma


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: UNII:4F4X42SYQ6

object_name: polyneuropathy, inflammatory demyelinating, chronic


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:D07V79Q44T

object_name: thyroid gland carcinoma


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: UNII:ZQ2KAH6G2Q

subject_name: BIFIDOBACTERIUM BIFIDUM R0071

object_name: Body Height


subject: UNII:ZQ2KAH6G2Q

object_name: body weight


subject: UMLS:C5666932

subject_name: Bacterial Type III Secretion-based Agent T3P-Y058-739

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:141441

subject_name: Ile-Thr


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Depressed mood


subject: CHEBI:8707

object_name: Cancer patients and suicide and depression


subject: CHEBI:8707

object_name: Depressed - symptom


subject: CHEBI:8707

object_name: Depression, CTCAE


subject: CHEBI:44915

subject_name: Propofol

object_name: cancer


subject: CHEBI:44915

object_name: neoplasm


subject: CHEBI:44915

object_name: Childhood Solid Neoplasm


subject: CHEBI:44915

object_name: Adult Solid Neoplasm


subject: CHEBI:44915

object_name: Solid Neoplasm


subject: CHEBI:44915

object_name: Primary malignant neoplasm


subject: CHEBI:44915

object_name: carcinoma


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:49086

object_name: delirium


subject: CHEBI:49086

object_name: Delirium, CTCAE


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:16436


subject: CHEBI:109549

subject_name: Ramelteon


subject: CHEBI:109549


subject: CHEBI:30742

subject_name: macrogol

object_name: Chronic constipation


subject: MESH:D004573

subject_name: Electrolytes


subject: UMLS:C3536863

subject_name: Electrolyte [EPC]


subject: CHEBI:8707

object_name: cannabis abuse


subject: CHEBI:7459

subject_name: Naloxone

object_name: Stress


subject: CHEBI:7459

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:7459

object_name: Back pain


subject: CHEBI:7459

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Ewing sarcoma of bone


subject: UNII:2S9ZZM9Q9V

object_name: extraskeletal Ewing sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent tumors of the Ewing's family


subject: UNII:2S9ZZM9Q9V

object_name: Ewing sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: peripheral primitive neuroectodermal tumor


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:201431

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:201431

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:201431

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:201431

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:201431

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:201431

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:201431

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:201431

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:201431

object_name: myelodysplastic syndrome with multilineage dysplasia


subject: CHEBI:201431

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: DRUGBANK:DB14304

subject_name: San-Chi

object_name: Angina pectoris


subject: MESH:C587496

subject_name: sanqi


subject: UMLS:C4289938

subject_name: Balanced Crystalloid Solution

object_name: septic shock


subject: UMLS:C4289938

object_name: Shock


subject: CHEBI:47426

subject_name: Furosemide

object_name: congestive heart failure


subject: CHEBI:47426

object_name: kidney failure


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: heart failure


subject: MESH:D012462


subject: MESH:D012462


subject: UMLS:C0879266

subject_name: Autologous Tumor Cell Vaccine

object_name: precancerous condition


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:44210114

object_name: schizophrenia 18


subject: CHEBI:31355

subject_name: Carboplatin

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:KZ3DLD11RQ

object_name: interstitial lung disease 1


subject: UNII:KZ3DLD11RQ

object_name: interstitial lung disease 2


subject: PUBCHEM.COMPOUND:45382195

subject_name: Thymosin Beta 4

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:45382195

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:45382195

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:45382195

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:45382195

object_name: coronary atherosclerosis


subject: UMLS:C0076616

subject_name: Thymosin beta-4


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: CHEBI:193615

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:193615

object_name: colorectal neoplasm


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine


subject: UMLS:C0947603


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Metastasis


subject: UNII:PQX0D8J21J

object_name: Metastatic Lesion


subject: UNII:PQX0D8J21J

object_name: Colorectal cancer stage IV


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:135659064

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:DPT0O3T46P

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UNII:DPT0O3T46P

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:DPT0O3T46P

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:DPT0O3T46P

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:8F5X4B082E

subject_name: Lixivaptan

object_name: HYPONATREMIA EUVOLEMIC


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Injury of musculoskeletal system


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: acute lymphoblastic leukemia


subject: UMLS:C1328139


subject: CHEBI:8871

subject_name: Risperidone

object_name: bipolar disorder


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: Abnormal left ventricular function


subject: PUBCHEM.COMPOUND:62690

subject_name: carbogen

object_name: Acute Ischemic Stroke


subject: PUBCHEM.COMPOUND:62690

object_name: Ischemic stroke


subject: CHEMBL.COMPOUND:CHEMBL4297716

subject_name: CARBOGEN


subject: CHEMBL.COMPOUND:CHEMBL4297716


subject: CHEMBL.COMPOUND:CHEMBL5095433

subject_name: ZILGANERSEN

object_name: Alexander disease


subject: CHEBI:166975

subject_name: soybean oil

object_name: pregnancy complicated by low implantation


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Primary malignant neoplasm


subject: UNII:M89N0Q7EQR

object_name: childhood malignant neoplasm


subject: UNII:M89N0Q7EQR

object_name: Malignant obstetric neoplasm


subject: PR:000001379


subject: PR:000001379

object_name: cancer


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: PR:000015561

subject_name: osteopontin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PR:000015561


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: psoriatic arthritis


subject: CHEBI:6413

subject_name: Letrozole

object_name: infertility


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: AIDS


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: primary hyperparathyroidism


subject: CHEBI:48390

subject_name: Cinacalcet


subject: CHEBI:48390

object_name: osteoporosis


subject: CHEBI:48390

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:48390

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:48390

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: epilepsy


subject: UMLS:C4527411

subject_name: BTK Inhibitor CT-1530

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C4527411

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4527411

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4527411

object_name: Diffuse follicle center lymphoma


subject: UMLS:C4301674

subject_name: Vasopressin V2 Receptor Antagonist

object_name: heart failure


subject: CHEBI:135901

subject_name: lanreotide

object_name: intestinal obstruction


subject: UMLS:C4721901

subject_name: Lanreotide Autogel


subject: GTOPDB:8451

subject_name: demcizumab

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: CHEMBL.COMPOUND:CHEMBL2109384

subject_name: DEMCIZUMAB


subject: UMLS:C2698134


subject: CHEBI:67272

subject_name: Perifosine

object_name: Plexosarcoma


subject: UMLS:C5907939

subject_name: DNA Polymerase Theta Inhibitor GSK4524101

object_name: neoplasm


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Serotonin deficiency


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:47426

subject_name: Furosemide

object_name: bronchiolitis


subject: DRUGBANK:DB16511

object_name: peritoneum cancer


subject: DRUGBANK:DB16511

object_name: ovarian carcinoma


subject: DRUGBANK:DB16511

object_name: malignant epithelial tumor of ovary


subject: DRUGBANK:DB16511

object_name: fallopian tube carcinoma


subject: DRUGBANK:DB16511

object_name: fallopian tube cancer


subject: UMLS:C4687482

subject_name: BRD4 Inhibitor PLX2853


subject: UMLS:C4687482


subject: UMLS:C4687482

object_name: female reproductive system neoplasm


subject: UMLS:C2604734

subject_name: briakinumab

object_name: Crohn disease


subject: CHEBI:141530

subject_name: Delanzomib

object_name: Solid Neoplasm


subject: CHEBI:141530

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:141530

object_name: non-Hodgkin lymphoma


subject: UMLS:C2352802


subject: UMLS:C2352802


subject: UMLS:C2352802


subject: CHEBI:88464

subject_name: (9E,11E)-octadecadienoic acid

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:88464

object_name: obesity


subject: CHEBI:88464

object_name: Obesity, CTCAE


subject: CHEBI:88464

object_name: Inflammation


subject: CHEBI:88464

object_name: inherited lipid metabolism disorder


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:36025


subject: CHEBI:36025


subject: CHEBI:36025


subject: CHEBI:36025


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: CHEBI:61159


subject: CHEBI:61159


subject: CHEBI:61159


subject: CHEBI:61159


subject: MESH:D044243

subject_name: Linoleic Acids, Conjugated


subject: MESH:D044243


subject: MESH:D044243


subject: MESH:D044243


subject: MESH:D044243


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Small cell lung cancer limited stage


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:91899

object_name: sinus congestion chronic


subject: CHEBI:91899

object_name: Chronic posterior ethmoidal sinusitis


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: hyperlipidemia


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Post-Traumatic Headache


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: rectal carcinoma


subject: CHEBI:72317

object_name: rectal cancer


subject: CHEBI:72317

object_name: Childhood Rectal Carcinoma


subject: CHEBI:72317

object_name: colorectal cancer


subject: CHEBI:72317

object_name: colorectal carcinoma


subject: CHEBI:72317

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:72317

object_name: colon carcinoma


subject: CHEBI:72317

object_name: colon cancer


subject: CHEBI:72317

object_name: colorectal adenocarcinoma


subject: CHEBI:72317

object_name: rectum adenocarcinoma


subject: CHEBI:72317

object_name: colon adenocarcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:136046

subject_name: Ripasudil

object_name: Fuchs' endothelial dystrophy


subject: UMLS:C4045500

subject_name: Glanatec


subject: UMLS:C2346882

subject_name: Autologous Dendritic Cell-Adenovirus CCL21 Vaccine

object_name: skin melanoma


subject: UMLS:C5446644

subject_name: Huangqi Guizhi Wuwu Decoction

object_name: diabetic kidney disease


subject: CHEBI:50217

subject_name: selegiline

object_name: Parkinson disease


subject: CHEBI:5523

subject_name: Goserelin

object_name: endometriosis


subject: CHEBI:5523

object_name: infertility


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: CHEBI:36704

subject_name: Imiquimod

object_name: influenza


subject: UMLS:C0357882

subject_name: aqueous cream bp


subject: UMLS:C5226607

object_name: psoriasis 14, pustular


subject: UMLS:C5226607

object_name: pustulosis palmaris et plantaris


subject: CHEMBL.COMPOUND:CHEMBL2108388

subject_name: FERUCARBOTRAN

object_name: type 1 diabetes mellitus 1


subject: CHEMBL.COMPOUND:CHEMBL2108388

object_name: type 1 diabetes mellitus


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Apathetic behavior due to dementia


subject: CHEBI:6887

object_name: cognitive disorder


subject: CHEBI:6887

object_name: Alzheimer disease type 1


subject: CHEBI:6887

object_name: Alzheimer disease


subject: CHEBI:6887

object_name: mild neurocognitive disorder


subject: CHEBI:6887

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat

object_name: fibromatosis


subject: PUBCHEM.COMPOUND:11670360

object_name: desmoid tumor


subject: PUBCHEM.COMPOUND:11670360

object_name: Desmoid tumor


subject: CHEBI:174806

subject_name: Nor-ketotifen


subject: CHEBI:174806

object_name: Influenza-like illness


subject: CHEBI:174806

object_name: Flu-Like Symptoms


subject: UNII:X97O9FTB92

subject_name: Verubulin

object_name: glioblastoma


subject: UNII:X97O9FTB92

object_name: Brain Stem Glioblastoma


subject: UNII:X97O9FTB92

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:138566969

subject_name: Baloxavir marboxil

object_name: influenza


subject: UNII:3I8JKL1CHB

object_name: metastatic neoplasm


subject: UNII:3I8JKL1CHB

object_name: Embolism, Tumor


subject: UNII:3I8JKL1CHB

object_name: Neoplasm Metastasis


subject: UNII:3I8JKL1CHB

object_name: Metastatic Lesion


subject: UNII:3I8JKL1CHB

object_name: Childhood Solid Neoplasm


subject: UNII:3I8JKL1CHB

object_name: Adult Solid Neoplasm


subject: UNII:3I8JKL1CHB

object_name: Solid Neoplasm


subject: UMLS:C3641173

subject_name: PROMITIL


subject: UMLS:C3641173


subject: UMLS:C3641173


subject: UMLS:C3641173


subject: UMLS:C3641173


subject: UMLS:C3641173


subject: UMLS:C3641173


subject: PUBCHEM.COMPOUND:16034857

subject_name: Duotrav

object_name: OPTN-related open angle glaucoma


subject: PUBCHEM.COMPOUND:16034857

object_name: open-angle glaucoma


subject: UMLS:C4733479

subject_name: changchun marina

object_name: non-small cell lung carcinoma


subject: CHEBI:91594


subject: UMLS:C0678133

subject_name: Taxol


subject: CHEBI:15379

subject_name: Oxygen

object_name: traumatic encephalopathy


subject: CHEBI:15379

object_name: traumatic brain injury


subject: CHEBI:15379

object_name: Military operations


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:38940

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: Ovarian cancer stage IV


subject: CHEBI:38940

object_name: recurrent primary peritoneal cavity cancer


subject: CHEBI:38940

object_name: stage IIIB ovarian epithelial cancer


subject: CHEBI:38940

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: FIGO Stage IIIA Ovarian Cancer


subject: CHEBI:38940

object_name: FIGO Stage IIIC Ovarian Cancer


subject: CHEBI:38940

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:38940

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:38940

object_name: stage IV primary peritoneal cavity cancer


subject: CHEBI:38940

object_name: stage IIIB primary peritoneal cavity cancer


subject: CHEBI:38940

object_name: stage IIIA primary peritoneal cavity cancer


subject: CHEBI:38940

object_name: stage IIIC primary peritoneal cavity cancer


subject: CHEBI:38940

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:38940

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:38940

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:38940

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:135029

subject_name: Cycloguanil

object_name: malaria


subject: CHEBI:8455

subject_name: Proguanil


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: Chronic small plaque psoriasis


subject: PUBCHEM.COMPOUND:134210715

subject_name: TIVUMECIRNON

object_name: Advanced cancer


subject: UMLS:C4763501


subject: CHEBI:39867

subject_name: Valproic acid

object_name: focal epilepsy


subject: UMLS:C0305852

subject_name: Depakote Sprinkle Capsules


subject: CHEBI:7514

subject_name: Neostigmine

object_name: ileus


subject: CHEBI:7514

object_name: Ileus, CTCAE


subject: CHEBI:7514

object_name: Ventral hernia


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:5494


subject: CHEBI:5494


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:94449


subject: CHEBI:94449


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:74030550


subject: PUBCHEM.COMPOUND:74030550


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Metastatic Breast Carcinoma


subject: CHEBI:85993

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:85993


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: UMLS:C3885141

object_name: tuberculosis


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine

object_name: sickle cell disease


subject: CHEBI:231324

subject_name: alpelisib

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: PUBCHEM.COMPOUND:42602260

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: breast cancer


subject: CHEBI:230905


subject: CHEBI:30742

subject_name: macrogol

object_name: colon (non-specific) lesion


subject: CHEBI:30742

object_name: polyp of colon


subject: CHEBI:28125

subject_name: Doconexent

object_name: hypertension, pregnancy-induced


subject: CHEBI:28125

object_name: Maternal hypertension


subject: CHEBI:8382

subject_name: Prednisone

object_name: IgA Nephropathy


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:15365

subject_name: Aspirin

object_name: brain infarction


subject: CHEBI:9757

subject_name: Tropicamide

object_name: type 1 diabetes mellitus 1


subject: CHEBI:9757

object_name: type 1 diabetes mellitus


subject: CHEBI:9757

object_name: type 2 diabetes mellitus


subject: CHEBI:125628

subject_name: Alisertib

object_name: Recurrent Rectal Cancer


subject: CHEBI:125628

object_name: colon mucinous adenocarcinoma


subject: CHEBI:125628

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:125628

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:125628

object_name: Colon cancer recurrent


subject: CHEBI:125628

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:125628

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:125628

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:125628

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: malignant soft tissue neoplasm


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Common Migraine


subject: UNII:C8ADC441ME

object_name: Headache


subject: UNII:C8ADC441ME

object_name: Headache, CTCAE


subject: CHEBI:8772

subject_name: Raloxifene

object_name: osteoporosis


subject: CHEBI:8772

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:8772

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:8772

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:76611

subject_name: flutemetamol

object_name: normal pressure hydrocephalus


subject: UMLS:C0009871

subject_name: Contraceptive Agents

object_name: infertility


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa


subject: UNII:6E6VJP68KR

subject_name: AZIMILIDE DIHYDROCHLORIDE

object_name: atrial fibrillation


subject: UNII:6E6VJP68KR

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:6E6VJP68KR

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:60939

subject_name: Azimilide


subject: PUBCHEM.COMPOUND:60939


subject: PUBCHEM.COMPOUND:60939


subject: UMLS:C1314817

subject_name: azimilide dihydrochloride


subject: UMLS:C1314817


subject: UMLS:C1314817


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: prostate cancer


subject: UNII:M487QF2F4V

object_name: prostate neoplasm


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:32300

subject_name: Voglibose

object_name: type 2 diabetes mellitus


subject: CHEBI:119915

subject_name: Fentanyl

object_name: separation anxiety disorder


subject: CHEBI:119915

object_name: Separation anxiety (finding)


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: PUBCHEM.COMPOUND:1805

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: borderline personality disorder


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:467LU0UCUW

subject_name: Sarizotan

object_name: Parkinson disease


subject: UNII:467LU0UCUW

object_name: Dyskinesia


subject: CHEBI:125628

subject_name: Alisertib

object_name: small cell lung carcinoma


subject: CHEBI:125628

object_name: ovarian cancer


subject: CHEBI:125628

object_name: ovarian neoplasm


subject: CHEBI:125628

object_name: ovarian carcinoma


subject: UNII:306ERL82IR

subject_name: Fexinidazole

object_name: Kala-Azar


subject: CHEBI:177298

object_name: pancreatic adenocarcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:15365

subject_name: Aspirin

object_name: Barrett esophagus


subject: CHEBI:15365

object_name: esophageal adenocarcinoma


subject: UMLS:C4733400

object_name: endometrial cancer


subject: UMLS:C4733400

object_name: uterine corpus cancer


subject: UMLS:C4733400

object_name: endometrial carcinoma


subject: UMLS:C4733400

object_name: Childhood Breast Carcinoma


subject: UMLS:C4733400

object_name: breast carcinoma


subject: UMLS:C4733400

object_name: breast cancer


subject: UMLS:C4733400

object_name: prostate carcinoma


subject: UMLS:C4733400

object_name: prostate cancer


subject: UMLS:C4733400


subject: UMLS:C4733400


subject: UMLS:C4733400


subject: UMLS:C4733400

object_name: salivary gland carcinoma


subject: UMLS:C4733400

object_name: salivary gland cancer


subject: UMLS:C4733400

object_name: cervical squamous cell carcinoma


subject: PUBCHEM.COMPOUND:16130933

subject_name: SOVATELITIDE

object_name: Acute Stroke


subject: PUBCHEM.COMPOUND:16130933

object_name: brain ischemia


subject: PUBCHEM.COMPOUND:16130933

object_name: cerebral infarction


subject: PUBCHEM.COMPOUND:16130933

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:16130933

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:18007905

subject_name: Sovateltide


subject: PUBCHEM.COMPOUND:18007905


subject: PUBCHEM.COMPOUND:18007905


subject: PUBCHEM.COMPOUND:18007905


subject: PUBCHEM.COMPOUND:18007905


subject: UNII:11X778QIZS

subject_name: sovateltide


subject: UNII:11X778QIZS


subject: UNII:11X778QIZS


subject: UNII:11X778QIZS


subject: UNII:11X778QIZS


subject: UMLS:C2348442


subject: UMLS:C2348442


subject: UMLS:C2348442


subject: UMLS:C2348442


subject: UMLS:C2348442


subject: UMLS:C5815531

subject_name: VaxSyn

object_name: HIV infection


subject: UMLS:C5815618

subject_name: Gp160 Vaccine


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE

object_name: kidney failure


subject: CHEBI:52251

subject_name: QUININE SULFATE


subject: CHEBI:94416


subject: CHEBI:15854

subject_name: Quinine


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Recurrent urinary tract infections


subject: CHEBI:6456

object_name: Hematuria, CTCAE


subject: CHEBI:6456

object_name: Hematuria


subject: CHEBI:6456

object_name: Dysuria


subject: CHEBI:6456

object_name: Dysuria, CTCAE


subject: UMLS:C1550678

subject_name: Water Specimen


subject: UMLS:C1550678


subject: UMLS:C1550678


subject: UMLS:C1550678


subject: UMLS:C1550678


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: UNII:QPQ082R25D

subject_name: Islatravir

object_name: HIV-1 infection


subject: CHEBI:94782

subject_name: Cediranib

object_name: colorectal neoplasm


subject: CHEBI:94782

object_name: breast neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:73579

subject_name: Leu-Val

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: Barrett esophagus


subject: UNII:DOB7Y3RSX0

object_name: in situ carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Cisgender


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:231594

object_name: Dysmenorrhea


subject: CHEBI:233291

subject_name: Saredutant

object_name: endogenous depression


subject: CHEBI:233291

object_name: major depressive disorder


subject: CHEBI:58097

object_name: Arthritis of knee


subject: CHEBI:58097

object_name: Acute Pain


subject: CHEBI:58097

object_name: Disorder of knee


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:32139

object_name: Contrast media reaction


subject: CHEBI:31348

subject_name: Capecitabine

object_name: adult hepatocellular carcinoma


subject: CHEBI:31348

object_name: liver cancer


subject: CHEBI:31348

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:31348

object_name: liver neoplasm


subject: CHEBI:31348

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:32127

subject_name: sevelamer

object_name: aneurysm


subject: CHEMBL.COMPOUND:CHEMBL5314349

subject_name: SEVELAMER


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: CHEBI:3310

subject_name: Calcium acetate


subject: PUBCHEM.COMPOUND:56674991

subject_name: Brincidofovir

object_name: adenoviridae infectious disease


subject: UMLS:C0260055

subject_name: Liquid nitrogen

object_name: common wart


subject: CHEBI:93862


subject: CHEBI:64213

subject_name: Cantharidin


subject: UMLS:C1541366

subject_name: Allogeneic GM-CSF-Secreting Breast Cancer Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C1541366

object_name: breast carcinoma


subject: UMLS:C1541366

object_name: breast cancer


subject: UMLS:C5418004

subject_name: Anti-PD-L1/IL-15 Fusion Protein KD033

object_name: Childhood Solid Neoplasm


subject: UMLS:C5418004

object_name: Adult Solid Neoplasm


subject: UMLS:C5418004

object_name: Solid Neoplasm


subject: CHEBI:32428

subject_name: cetoleic acid

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:32428

object_name: metabolic syndrome X


subject: CHEBI:180019

subject_name: Catelaidic acid


subject: CHEBI:180019


subject: UMLS:C4329442

object_name: neoplasm


subject: UMLS:C5703306

subject_name: Saposin C


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Depressed mood


subject: UNII:B72HH48FLU

object_name: Cancer patients and suicide and depression


subject: UNII:B72HH48FLU

object_name: Depressed - symptom


subject: UNII:B72HH48FLU

object_name: Depression, CTCAE


subject: CHEBI:119915

subject_name: Fentanyl

object_name: pain agnosia


subject: CHEBI:119915

object_name: Pain insensitivity


subject: UMLS:C5435096

object_name: Autoimmunity


subject: CHEBI:135686

subject_name: Alvimopan

object_name: bowel dysfunction


subject: CHEBI:135686

object_name: intestinal disorder


subject: UMLS:C4045524

object_name: non-small cell lung carcinoma


subject: UMLS:C4045524


subject: CHEBI:32696

object_name: colorectal cancer


subject: CHEBI:32696

object_name: colorectal carcinoma


subject: CHEBI:32696

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:8207

subject_name: Pilocarpine

object_name: presbyopia


subject: CHEMBL.COMPOUND:CHEMBL3544963

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3544963

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3544963

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3544963

object_name: pediatric lymphoma


subject: UMLS:C3640223

subject_name: TORC1/2 Kinase Inhibitor DS-3078a


subject: UMLS:C3640223


subject: UMLS:C3640223